The Abramson Cancer Center of the University of Pennsylvania is a national leader in the field of gastrointestinal cancer genetics. Penn Medicine was one of the first in the country to establish a Gastrointestinal (GI) Cancer Risk Evaluation Program.
If concerned about the risk of gastrointestinal cancer, it's important to have the best team of experts.
The GI Cancer Risk Evaluation Program at the Abramson Cancer Center has specialists nationally recognized for their expertise in cancer and genetics and can provide information, care and support to help patients throughout the entire risk evaluation program.
Penn's GI Cancer Risk team is familiar with and able to provide clinical, genetic and research services for people with concerns about the following conditions:
Those who may have an increased risk of an inherited gastrointestinal cancer include:
If a patient, or a relative of a patient is concerned about their risk for developing gastrointestinal cancer, The Gastrointestinal Cancer Risk Evaluation Program can help answer such questions as:
For more information about the program, or to download an application for the program, visit Penn Medicine’s Gastroenterology division website.
To learn about what sets us apart, visit:
By the age of seven, Tanya Zekovitch already understood what it was like to be a cancer patient after being treated for Ewing's Sarcoma, a rare form of bone cancer. So when she was diagnosed with Acute Myeloid Leukemia in the summer
Watch CANPrevent Colorectal Cancer Conference to learn about your risk for developing colorectal cancer.
Watch Focus on Gastrointestinal Cancers Conference - Get information on the latest advances in gastrointestinal cancer risk, prevention, diagnosis, treatment, symptom management and psychosocial issues.
Watch Focus On Pancreatic Cancer Conference - Get information on the latest advances in pancreatic cancer risk, prevention, diagnosis, treatment, symptom management and psychosocial issues.
NBC10 Colorectal Cancer Awareness Month
Video with Dr. Gregory Ginsberg
OncoLink's" The Basics" -- Learn basic information about different gastrointestinal cancers.
Abramson Cancer Centers Gastrointestinal Cancer Program is conducting exciting, innovation research entitled "The Mechanisms of Esophageal Carcinogenesis." This important project will define underlying mechanisms in the development of esophageal cancer that will lead to new ways to diagnose and treat this cancer. Find out more...
Clinical trials are studies to find new ways to prevent, detect and treat cancer. The purpose of each clinical trial is to answer a specific question. Our physicians carefully design these studies to find new ways to improve care and quality of life ...